"Part of Strong Memorial Hospital."

During the past decade, UR Dermatology at College Town conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 1 clinical trials were completed, i.e. on average, 16.7% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 1 clinical trials were completed. i.e. 25% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "UR Dermatology at College Town" #1 collaborator was "Incyte Corporation" with 2 trials as a collaborator and "Regeneron Pharmaceuticals" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "UR Dermatology at College Town" are "Alopecia Areata" (2 trials), "Dermatitis, Atopic" (2 trials), "Chronic Hand Dermatitis" (1 trials), "Dermatitis" (1 trials) and "Discoid Lupus Erythematosus" (1 trials). Many other conditions were trialed in "UR Dermatology at College Town" in a lesser frequency.

Most popular intervention types in "UR Dermatology at College Town" are "Drug" (6 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "Ruxolitinib" (2 trials), "Abrocitinib 100 mg" (1 trials), "Abrocitinib 200 mg" (1 trials) and "CTP-543" (1 trials). Other intervention names were less common.

The vast majority of trials in "UR Dermatology at College Town" are 6 trials for "All" genders.

Currently, there are 5 active trials in "UR Dermatology at College Town". 1 are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and 2 are Enrolling by invitation. In total, there were 1 completed trials in UR Dermatology at College Town, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in UR Dermatology at College Town, 1 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".